These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12777666)

  • 1. Contrast-media induced nephropathy in patients undergoing coronary angiography.
    Gomes VO; Blaya P; Poli de Figueiredo CE; Manfroi W; Caramori P
    J Invasive Cardiol; 2003 Jun; 15(6):304-10. PubMed ID: 12777666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiocontrast-induced nephropathy.
    Carver JR
    J Invasive Cardiol; 2003 Jun; 15(6):315-6. PubMed ID: 12777668
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients.
    Madyoon H
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S26-30. PubMed ID: 12439365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
    Kini AA; Sharma SK
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S19-25. PubMed ID: 12439364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of radiocontrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography.
    Tadros GM; Mouhayar EN; Akinwande AO; Campbell B; Wood C; Blankenship JA
    J Invasive Cardiol; 2003 Jun; 15(6):311-4. PubMed ID: 12777667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical burden of contrast media-induced nephropathy.
    Liistro F; Falsini G; Bolognese L
    Ital Heart J; 2003 Oct; 4(10):668-76. PubMed ID: 14664279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of radiocontrast-induced nephropathy.
    Baker CS
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):532-8. PubMed ID: 12652507
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contrast-induced nephropathy: An update].
    Spagnoli V; Azzalini L; Tadros VX; Picard F; Ly HQ
    Ann Cardiol Angeiol (Paris); 2016 Apr; 65(2):87-94. PubMed ID: 26926776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies.
    Azzalini L; Spagnoli V; Ly HQ
    Can J Cardiol; 2016 Feb; 32(2):247-55. PubMed ID: 26277092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a predictive risk score for radiocontrast-induced nephropathy following percutaneous coronary intervention.
    Skelding KA; Best PJ; Bartholomew BA; Lennon RJ; O'Neill WW; Rihal CS
    J Invasive Cardiol; 2007 May; 19(5):229-33. PubMed ID: 17476039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of radiocontrast nephropathy and use of fenoldopam for its prevention.
    Mathur VS
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S4-8. PubMed ID: 12439361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race and contrast-induced nephropathy in patients undergoing coronary angiography and cardiac catheterization.
    Chawla R; Turlington J; Arora P; Jovin IS
    Int J Cardiol; 2017 Mar; 230():610-613. PubMed ID: 28040287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiocontrast nephropathy: managing the high-risk patient. Introduction.
    Lepor NE
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S1-3. PubMed ID: 12508796
    [No Abstract]   [Full Text] [Related]  

  • 17. Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and intervention.
    Duffy SJ; Ruygrok P; Juergens CP; Sievert H; Richards M; Blake J; Whitbourn R; Farouque HO; Pertile T; Kaye DM
    J Am Coll Cardiol; 2010 Aug; 56(6):525-6. PubMed ID: 20670766
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.
    Durham JD; Caputo C; Dokko J; Zaharakis T; Pahlavan M; Keltz J; Dutka P; Marzo K; Maesaka JK; Fishbane S
    Kidney Int; 2002 Dec; 62(6):2202-7. PubMed ID: 12427146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing the unpreventable? Rotational angiography for the prevention of contrast-induced nephropathy.
    Menon D; Gruberg L
    J Invasive Cardiol; 2010 Sep; 22(9):432-3. PubMed ID: 20814051
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.